Profound Medical Corp.

NASDAQ: PROF · Real-Time Price · USD
4.35
-1.19 (-21.48%)
At close: Aug 15, 2025, 3:48 PM

Profound Medical Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
54.91M 26.21M 46.52M 67.15M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a 4.58M
Other Long-Term Assets
419.01K n/a n/a 3.62M
Receivables
7.04M 7.29M 6.34M 1.41M
Inventory
5.8M 6.99M 7.94M 7.41M
Other Current Assets
n/a n/a 21.95M 20.3M
Total Current Assets
69.06M 41.9M 62.02M 77.13M
Property-Plant & Equipment
489K 1.52M 1.72M 1.9M
Goodwill & Intangibles
261K 490K 680K 4.12M
Total Long-Term Assets
1.17M 2.06M 2.4M 9.65M
Total Assets
70.23M 43.96M 64.42M 86.78M
Account Payables
1.32M 3.28M 2.03M 3.18M
Deferred Revenue
419K 717.31K 471K 477K
Short-Term Debt
1.74M 2.1M 523K n/a
Other Current Liabilities
1.03M 3.69K 621K 248K
Total Current Liabilities
6.57M 6.37M 4.18M 4.16M
Long-Term Debt
2.92M 5M 10.11M n/a
Other Long-Term Liabilities
121.74K 73K -3.46M 1.4M
Total Long-Term Liabilities
3.25M 6.37M 8.23M 2M
Total Liabilities
9.81M 12.73M 12.42M 6.16M
Total Debt
5.12M 7.87M 8.23M 1.38M
Common Stock
281.38M 222.21M 205.82M 219.58M
Retained Earnings
-245.02M -216.24M -189.36M -160.69M
Comprehensive Income
2.74M 5.57M 16.84M 4.75M
Shareholders Equity
60.39M 31.18M 52M 80.62M
Total Investments
n/a n/a n/a 4.58M